По вашему запросу найдено документов: 77

Страница 2 из 8

Биологические методы диагностики депрессивных симптомов при шизофрении: нарративный обзор литературы
Biological Methods for Diagnosing Depressive Symptoms in Patients with Schizophrenia: A Narrative Review
Sultanova, Renata, Gashkarimov, Vadim, Efremov, Ilya, Asadullin, Azat, Султанова, Рената, Гашкаримов, Вадим, Ефремов, Илья, Асадуллин, Азат (2024)
Biological Methods for Diagnosing Depressive Symptoms in Patients with Schizophrenia: A Narrative
Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic
Santomauro, DF, Herrera, AMM, Shadid, J, Zheng, P, Ashbaugh, C, Pigott, DM, Abbafati, C, Adolph, C, Amlag, JO, Aravkin, AY, Bang-Jensen, BL, Idrisov, B, Group Author (2021)
, with depressive and anxiety disorders being leading contributors to this burden. The emergence of the COVID-19
Астеническое расстройство после инсульта
Poststroke Asthenic Disorder
Kutlubaev, Mansur A., Akhmetova, Albina I., Кутлубаев, М.А., Ахметова, А.И. (2023)
depression
Selective Serotonin Reuptake Inhibitors for Stroke Recovery
Hua, Xing, Wu, Simiao, Legg, Lynn A., Rudberg, Ann-Sofie, Hackett, Maree L., Tilney, Russel, Tilney, Russel, Kutlubaev, Mansur A., Hsieh, Cheng-Fang, Barugh, Amanda J., Hankey, Graeme J., Lundström, Erik (2022)
depression
КОГНИТИВНЫЕ НАРУШЕНИЯ, ТРЕВОГА И ДЕПРЕССИЯ У ПАЦИЕНТОВ С ХРОНИЧЕСКИМИ ЛИМФОПРОЛИФЕРАТИВНЫМИ ЗАБОЛЕВАНИЯМИ
COGNITIVE IMPAIRMENT, ANXIETY, AND DEPRESSION IN PATIENTS WITH CHRONIC LYMPHOPROLIFERATIVE DISEASES
ТЕРЕГУЛОВА, Д.Р., АХМАДЕЕВА, Л.Р., БАКИРОВ, Б.А., TEREGULOVA, D.R., AKHMADEEVA, L.R., BAKIROV, B.A. (2021)
COGNITIVE IMPAIRMENT, ANXIETY, AND DEPRESSION IN PATIENTS WITH CHRONIC LYMPHOPROLIFERATIVE DISEASES
ОТЯГОЩЕННОСТЬ СИНДРОМА ОТМЕНЫ АЛКОГОЛЯ СУДОРОЖНЫМИ ПРИПАДКАМИ И АЛКОГОЛЬНЫМ ДЕЛИРИЕМ У ПАЦИЕНТОВ С КОМОРБИДНОЙ ДЕПРЕССИЕЙ
BURDENESS OF ALCOHOLWITHDRAWAL SYNDROME WITH SEIZURES AND ALCOHOLIC DELIRIOUS IN PATIENTS WITH COMORBID DEPRESSION
Тулбаева, Н.Р., Tulbaeva, N.R. (2022)
WITH COMORBID DEPRESSION
Neuropsychiatric Manifestations of Amyotrophic Lateral Sclerosis
Kutlubaev, M.A., Pervushina, E.V., Areprintseva, D.K., Mendelevich, V.D., Brylev, L.V. (2023)
dementia, especially in the fi rst months after diagnosis, there is a high risk of developing depressive
Individual Differences in Relative Telomere Length in Mentally Healthy Subjects: The Effect of TERT Gene Polymorphism and Urban Residency
Kazantseva, A.V., Davydova, Yu. D., Enikeeva, R.F., Mustafin, R.N., Lobaskova, M.M., Malykh, S.B., Khusnutdinova, E.K. (2022)
literature are related to depressive disorders. However, the use of the telomere length as a biomarker
Assessment of the 3-substituted thietane-1,1-dioxide derivative antidepressant effect using rat model of depression induced by reserpine
Nikitina, Irina L., Gaisina, Gulnara G., Klen, Elena E., Tkachenko, Lyubov A. (2025)
. The aim of the study was to evaluate the antidepressant effect of 3ETD in a model of depressive-like state
ЧАСТОТА ПРОЯВЛЕНИЯ ДЕПРЕССИВНЫХ И ТРЕВОЖНЫХ РАССТРОЙСТВ У ПАЦИЕНТОВ С COVID-19
INCIDENCE OF DEPRESSIVE AND ANXIETY DISORDERS IN COVID-19 PATIENTS
В.Н. Павлов, КАРПОВ, Д. А., САФИН, Ш. М., ЮЛДАШЕВ, В. Л., V.N. Pavlov, KARPOV, D. A., SAFIN, SH. M., YULDASHEV, V. L. (2020)
INCIDENCE OF DEPRESSIVE AND ANXIETY DISORDERS IN COVID-19 PATIENTS

Страница 2 из 8

Google Scholar
OpenDoar

Фасеты

Научный руководитель
Авторы
Ключевые слова
Год